December 07, 2011
Lannett Co. Inc. on Tuesday resolved its antitrust suit in Pennsylvania federal court alleging Celgene Corp. unfairly blocked it from launching a generic version of Celgene's thalidomide-based cancer drug Thalomid.
March 31, 2011
A federal judge in Pennsylvania on Thursday denied a second attempt by Celgene Corp. to dismiss an antitrust complaint by a generics maker that wants to market a version of the company's thalidomide-based cancer drug Thalomid.
March 29, 2011
A Pennsylvania federal judge on Tuesday shot down Lannett Co. Inc.'s attempt to enforce what it claimed was an oral agreement with Celgene Corp. to settle an antitrust suit over cancer drug Thalomid.